Slides and webcasts from this ESMO Preceptorship course are open to all with at least a free ESMO account, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.
ESMO Virtual Preceptorship on Metastatic Bladder and Kidney Cancer 2020: November
- Start date
- 27 Nov 2020
- End date
- 28 Nov 2020
- Location
- Virtual, CET Time
Learning objectives
- To learn about fundamentals of molecular pathology and diagnosis as contributing factors to heterogeneity in bladder and kidney cancer
- To understand essentials in the assessment and multidisciplinary treatment of bladder and kidney cancer
- To learn about advances in treatment and novel targets in bladder and kidney cancer
Accreditation
The programme of this virtual event has been accredited with 6 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
- Aristotelis Bamias, Greece
- Camillo Porta, Italy
